Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 results for antineoplaston therapy in patients with refractory brain tumors were reported; the study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• Antineoplaston AS2-1 (AS2-1)

Snippet

Sponsor: Burzynski Research Institute | Conditions: Refractory Brain Tumors | Phase 2 | Status: COMPLETED | Results posted: 2016-12-16